BACKGROUND
Thyroid cancer is common. Fortunately, thyroid cancer has an excellent prognosis as we have very effective treatments. The initial treatment for thyroid cancer is usually surgery, and often this is the only treatment needed. For patients with more advanced cancer, radioactive iodine therapy serves as a “magic bullet” to seek out and destroy thyroid cancer cells. Doctors know that radioactive iodine therapy helps people with high-risk thyroid cancer, and that it is usually not needed for low-risk cancer. But for people with intermediaterisk thyroid cancer, it is still unclear if radioactive iodine therapy is helpful. Because of this uncertainty, doctors are encouraged to make decisions together with patients.

This study developed a decision aid to help patients to determine the need for radioactive iodine therapy after surgery for intermediate-risk thyroid cancer. The investigators asked patients to complete surveys and join group discussions about how they made their treatment decisions.

THE FULL ARTICLE TITLE
Carr AL et al. Patient perspectives toward a decision aid for radioactive iodine treatment for intermediate risk thyroid cancer. Int J Behav Med. Epub 2025 Dec 18; doi: 10.1007/s12529-025-10408-4. PMID: 41413365.

SUMMARY OF THE STUDY
This study involved 23 adults with thyroid cancer who were offered radioactive iodine therapy. Patients completed surveys and participated in focus groups exploring decision- making experiences, informational needs, and recommendations for a web-based patient decision aid.

The results of these surveys highlighted three broad areas: (1) the range of patient involvement in the decisionmaking process for radioactive iodine therapy, with some patients unaware that declining radioactive iodine therapy was an option; (2) personal values–based decision outcomes; and (3) recommendations for decisionaid content based on patients’ knowledge gaps about radioactive iodine therapy. Recommendations from patients included the need for more information about the radioactive iodine dose, common side effects of radioactive iodine therapy, safety precautions for radioactivity,

WHAT ARE THE IMPLICATIONS OF THIS STUDY?
This study showed that many patients with intermediaterisk thyroid cancer feel uncertain about whether to get radioactive iodine therapy and may not receive enough information to make a confident decision. A decision aid tool is helpful in explaining the risks and benefits of radioactive iodine therapy, what the treatment involves and how it may affect daily life. This could help patients choose the option that fits their goals and values and help patients understand their options can lead to better decisions and fewer unnecessary treatments.

— Joanna Miragaya, MD

Table of Contents | PDF File for Saving and Printing